Unicycive Therapeutics, Inc. (UNCY) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Unicycive Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -34.52x | -1.45x | -0.70x | -0.45x | -2.40x | -30.40x |
| P/B Ratio | 30.36x | 7.16x | -5.59x | -17.45x | 1.46x | -28.54x |
| P/S Ratio | 0.00x | 0.00x | 31.56x | 8.55x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 100.0% | 100.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | -3077.6% | -1898.2% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | -4525.0% | -1898.8% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | -4470.8% | -1881.3% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 2.59x | 1.28x | 0.76x | 0.81x | 8.75x | 0.07x |
| Quick Ratio | 2.59x | 1.28x | 0.76x | 0.81x | 8.75x | 0.07x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.10x | -0.21x | -0.43x | 0.02x | -0.94x |
YoY = year-over-year change. Source: FMP..